IRQ audio 2
With ever-evolving technologies, cancer treatments will almost certainly become more effective and less invasive in the future. A new procedure that will likely play an important role in the future of interventional oncology is histotripsy. While the procedure could be adopted by a variety of specialties, we believe that interventional oncologists are well-positioned and best equipped to lead the introduction and clinical translation of this new technology.
In the audio version of "Breaking down histotripsy: Inside a new ablation modality with cancer applications" (Fall 2021 IR Quarterly, pp. 12-14), authors Fred T. Lee, MD, Timothy J. Ziemlewicz, MD, Zhen Xu, PhD, and Paul Laeseke MD, PhD, describe the potential for histotripsy in cancer treatment and the critical role interventional oncologists will play.
Podcast participants
Fred T. Lee, MD, is a professor of radiology, biomedical engineering, and urology, the Robert Turrel Professor of Medical Imaging, and the chief of abdominal intervention at the University of Wisconsin-Madison.
Timothy J. Ziemlewicz, MD, is an associate professor of radiology in the abdominal imaging and intervention section at the University of Wisconsin.
Zhen Xu, PhD, is a professor of biomedical engineering at the University of Michigan.
Paul Laeseke MD, PhD, is an assistant professor of radiology in the Interventional Radiology Section at the University of Wisconsin.
Contact us with your ideas and questions, or read more about interventional radiology in IR Quarterly magazine or SIR's Patient Center.
